Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis and higher rheumatoid factor demonstrated better DAS28-CRP improvement with ...
In the initial EXXELERATE trial comparing the efficacy of CIMZIA and adalimumab, the primary endpoints of superiority were not met. In the post hoc analysis, efficacy outcomes in CIMZIA and adalimumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results